TY - JOUR
T1 - Left atrial myopathy in cardiac amyloidosis
T2 - Implications of novel echocardiographic techniques
AU - Modesto, Karen M.
AU - Dispenzieri, Angela
AU - Cauduro, Sanderson A.
AU - Lacy, Martha
AU - Khandheria, Bijoy K.
AU - Pellikka, Patricia A.
AU - Belohlavek, Marek
AU - Seward, James B.
AU - Kyle, Robert
AU - Tajik, A. Jamil
AU - Gertz, Morie
AU - Abraham, Theodore P.
PY - 2005/1
Y1 - 2005/1
N2 - Aims: To assess left atrial (LA) function and determine the prevalence of LA dysfunction in AL amyloidosis (AL) using conventional and strain echocardiography. Methods and results: LA ejection fraction, LA filling fraction, LA ejection force, peak LA systolic strain rate (LAsSR), and LA systolic strain (LA ε) were determined in 95 AL patients (70 with and 25 without echocardiographic evidence of cardiac involvement, abbreviated CAL and NCAL, respectively), 30 age-matched controls (CON), and 20 patients with diastolic dysfunction and LA dilatation (DD). Peak LAsSR >2 standard deviations below mean CON value was used as the cut-off for normal LA function. LA ejection fraction was lower in CAL when compared with CON (40.4 ± 13.6 vs. 67.0 ± 6%, P = 0.01). Left atrial septal strain rate and strain were lower in CAL (0.8 ± 0.5 s-1 and 5.5 ± 4%, respectively) compared with CON (1.8 ± 0.8 s-1 and 14 ± 4%, respectively, P = <0.0001), NCAL (1.6 ± 0.8 s-1 and 13 ± 7%, respectively, P < 0.0001) and DD (1.3 ± 0.4 s -1 and 10 ± 2%, respectively, P < 0.0001). Based on peak LA systolic strain rate criteria, the cut-off values for normal LA function were -1.1 s-1 and -1.05 s-1 for lateral and septal walls. Using these criteria, LA dysfunction was identified in 32% (lateral LA criteria) and 60% (septal LA criteria) of CAL patients. Lateral and septal LAsSR were lower in CAL patients with vs. those without symptoms of heart failure. Inter- and intra-observer agreement was high for LA strain echocardiography. Conclusion: LA function assessment using strain echocardiography is feasible with low intra- and inter-observer variability. LA dysfunction is observed in AL patients without other echocardiographic features of cardiac involvement and may contribute to cardiac symptoms in CAL.
AB - Aims: To assess left atrial (LA) function and determine the prevalence of LA dysfunction in AL amyloidosis (AL) using conventional and strain echocardiography. Methods and results: LA ejection fraction, LA filling fraction, LA ejection force, peak LA systolic strain rate (LAsSR), and LA systolic strain (LA ε) were determined in 95 AL patients (70 with and 25 without echocardiographic evidence of cardiac involvement, abbreviated CAL and NCAL, respectively), 30 age-matched controls (CON), and 20 patients with diastolic dysfunction and LA dilatation (DD). Peak LAsSR >2 standard deviations below mean CON value was used as the cut-off for normal LA function. LA ejection fraction was lower in CAL when compared with CON (40.4 ± 13.6 vs. 67.0 ± 6%, P = 0.01). Left atrial septal strain rate and strain were lower in CAL (0.8 ± 0.5 s-1 and 5.5 ± 4%, respectively) compared with CON (1.8 ± 0.8 s-1 and 14 ± 4%, respectively, P = <0.0001), NCAL (1.6 ± 0.8 s-1 and 13 ± 7%, respectively, P < 0.0001) and DD (1.3 ± 0.4 s -1 and 10 ± 2%, respectively, P < 0.0001). Based on peak LA systolic strain rate criteria, the cut-off values for normal LA function were -1.1 s-1 and -1.05 s-1 for lateral and septal walls. Using these criteria, LA dysfunction was identified in 32% (lateral LA criteria) and 60% (septal LA criteria) of CAL patients. Lateral and septal LAsSR were lower in CAL patients with vs. those without symptoms of heart failure. Inter- and intra-observer agreement was high for LA strain echocardiography. Conclusion: LA function assessment using strain echocardiography is feasible with low intra- and inter-observer variability. LA dysfunction is observed in AL patients without other echocardiographic features of cardiac involvement and may contribute to cardiac symptoms in CAL.
KW - Amyloidosis
KW - Atrial function
KW - Echocardiography
KW - Strain
UR - http://www.scopus.com/inward/record.url?scp=20044369352&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20044369352&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehi040
DO - 10.1093/eurheartj/ehi040
M3 - Article
C2 - 15618074
AN - SCOPUS:20044369352
SN - 0195-668X
VL - 26
SP - 173
EP - 179
JO - European Heart Journal
JF - European Heart Journal
IS - 2
ER -